Wong, H.T.tran. 2026. How Does CAR-T Therapy’s Efficacy Translate to Clinical Value for Hong Kong Patients with Refractory Hematological Malignancies, and How Can Optimized Manufacturing Help Close the Current Access Gap?. Journal of Medicine and Life Sciences. 2, 1 (Apr. 2026), 53–70. DOI:https://doi.org/10.71222/dt007s28.